These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38613685)

  • 21. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
    Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
    Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Oxytocin Administration on Cue-Induced Craving in Co-occurring Alcohol Use Disorder and PTSD: A Within-Participant Randomized Clinical Trial.
    Stauffer CS; Meinzer NK; Morrison T; Wen JH; Radanovich L; Leung D; Niles A; O'Donovan A; Batki SL; Woolley JD
    Alcohol Clin Exp Res; 2019 Dec; 43(12):2627-2636. PubMed ID: 31610033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.
    Grodin EN; Bujarski S; Towns B; Burnette E; Nieto S; Lim A; Lin J; Miotto K; Gillis A; Irwin MR; Evans C; Ray LA
    Transl Psychiatry; 2021 Jun; 11(1):355. PubMed ID: 34120149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation.
    Leggio L; Zywiak WH; Fricchione SR; Edwards SM; de la Monte SM; Swift RM; Kenna GA
    Biol Psychiatry; 2014 Nov; 76(9):734-41. PubMed ID: 24775991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial.
    Zimmermann S; Thomas BC; Krisam J; Limprecht R; Klose C; Stenger M; Pourbaix M; Ries M; Vollstaedt-Klein S; Koopmann A; Lenz B; Kiefer F; Bach P
    BMJ Open; 2022 Apr; 12(4):e059672. PubMed ID: 35410938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the efficiency of virtual reality in the treatment of alcohol use disorder: study protocol for a randomized controlled trial : E-Reva.
    Nègre F; Lemercier-Dugarin M; Gomet R; Pelissolo A; Malbos E; Romo L; Zerdazi EH
    Trials; 2024 Jun; 25(1):417. PubMed ID: 38937776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Lim AC; Roche DJO; Ray LA
    J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
    Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
    Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
    Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
    Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.
    Ray LA; Bujarski S; Shoptaw S; Roche DJ; Heinzerling K; Miotto K
    Neuropsychopharmacology; 2017 Aug; 42(9):1776-1788. PubMed ID: 28091532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
    Rose AK; Jones A
    Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative affect and alcohol craving in trauma-exposed young adult drinkers.
    Berenz EC; Edalatian Zakeri S; Demos AP; Paltell KC; Bing-Canar H; Kevorkian S; Ranney R
    Alcohol Clin Exp Res; 2021 Jul; 45(7):1479-1493. PubMed ID: 34241905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure to Stigma Elicits Negative Affect and Alcohol Craving Among Young Adult Sexual Minority Heavy Drinkers.
    Mereish EH; Miranda R
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1263-1272. PubMed ID: 31099903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the cue-availability paradigm to assess cue reactivity.
    Davidson D; Tiffany ST; Johnston W; Flury L; Li TK
    Alcohol Clin Exp Res; 2003 Aug; 27(8):1251-6. PubMed ID: 12966318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher levels of trait impulsiveness and a less effective response inhibition are linked to more intense cue-elicited craving for alcohol in alcohol-dependent patients.
    Papachristou H; Nederkoorn C; Havermans R; Bongers P; Beunen S; Jansen A
    Psychopharmacology (Berl); 2013 Aug; 228(4):641-9. PubMed ID: 23508556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.
    Nieto SJ; Grodin EN; Burnette EM; Cahill CM; Ray LA
    Alcohol Alcohol; 2022 Nov; 57(6):727-733. PubMed ID: 35788255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach.
    MacKillop J; Few LR; Stojek MK; Murphy CM; Malutinok SF; Johnson FT; Hofmann SG; McGeary JE; Swift RM; Monti PM
    Transl Psychiatry; 2015 Apr; 5(4):e544. PubMed ID: 25849983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
    Ray LA; Chin PF; Heydari A; Miotto K
    Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6, but not TNF-α, response to alcohol cues and acute consumption associated with neural cue reactivity, craving, and future drinking in binge drinkers.
    Blaine SK; Ridner CM; Campbell BR; Crone L; Claus ED; Wilson JR; West SN; McClanahan AJ; Siddiq AS; Layman IMP; Macatee R; Ansell EB; Robinson JL; Beck DT
    Brain Behav Immun Health; 2023 Aug; 31():100645. PubMed ID: 37484196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study.
    Khemiri L; Steensland P; Guterstam J; Beck O; Carlsson A; Franck J; Jayaram-Lindström N
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2240-51. PubMed ID: 26482910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.